LIFELONG PROPHYLAXIS WITH TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PREVENTION OF OUTBREAK OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN KIDNEY TRANSPLANT RECIPIENTS

被引：0
|
作者：
Goto, Norihiko [1 ]
Takahashi-Nakazato, Ai [2 ]
Futamura, Kenta [1 ]
Okada, Manabu [1 ]
Tsujita, Makoto [1 ]
Hiramitsu, Takahisa [1 ]
Narumi, Shunji [1 ]
Oka, Shinichi [2 ]
Watarai, Yoshihiko [1 ]
机构：
[1] Nagoya Daini Red Cross Hosp, Renal Ctr, Nagoya, Aichi, Japan
[2] Natl Ctr Global Hlth & Med, Aids Clin Ctr, Tokyo, Japan
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
BOS501
引用
收藏
页码：309 / 309
页数：1
相关论文
共 50 条
  • [1] Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients
    Zmarlicka, Monika
    Martin, Spencer T.
    Cardwell, Sophia M.
    Nailor, Michael D.
    PROGRESS IN TRANSPLANTATION, 2015, 25 (03) : 210 - 216
  • [2] PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA IN CARDIAC TRANSPLANT RECIPIENTS BY TRIMETHOPRIM-SULFAMETHOXAZOLE
    OLSEN, SL
    RENLUND, DG
    OCONNELL, JB
    TAYLOR, DO
    LASSETTER, JE
    EASTBURN, TE
    HAMMOND, EH
    BRISTOW, MR
    TRANSPLANTATION, 1993, 56 (02) : 359 - 362
  • [3] Once weekly trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis in children with cancer
    McMullan, Brendan
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2014, 50 (06) : 491 - 491
  • [4] 'Once weekly trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis in children with cancer'
    McMullan, Brendan
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2014, 50 (05) : 415 - 415
  • [5] Methotrexate and Trimethoprim-Sulfamethoxazole for Pneumocystis pneumonia Prophylaxis
    Yamazaki, Hayato
    Nanki, Toshihiro
    Miyasaka, Nobuyuki
    Harigai, Masayoshi
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (04) : 777 - 778
  • [6] Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
    G. V. Ramesh Prasad
    Jill Beckley
    Mohit Mathur
    Madhushankar Gunasekaran
    Michelle M. Nash
    Lindita Rapi
    Michael Huang
    Jeffrey S. Zaltzman
    BMC Infectious Diseases, 19
  • [7] Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
    Prasad, G. V. Ramesh
    Beckley, Jill
    Mathur, Mohit
    Gunasekaran, Madhushankar
    Nash, Michelle M.
    Rapi, Lindita
    Huang, Michael
    Zaltzman, Jeffrey S.
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [8] Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation
    Gabardi, Steven
    Millen, Peter
    Hurwitz, Shelley
    Martin, Spencer
    Roberts, Keri
    Chandraker, Anil
    CLINICAL TRANSPLANTATION, 2012, 26 (03) : E184 - E190
  • [9] Evaluation of Pneumocystis jirovecii Pneumonia Prophylaxis among Kidney and Liver Transplant Recipients; Trimethoprim/Sulfamethoxazole vs Alternative Therapies.
    Aldag, E.
    Pagels, C.
    Pedersen, R.
    Nadeem, I.
    Gunabushanam, V.
    Sahajpal, A.
    Dilworth, T. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 728 - 728
  • [10] A Case of Pneumonia Caused by Pneumocystis jirovecii Resistant to Trimethoprim-Sulfamethoxazole
    Lee, Sang Min
    Cho, Yong Kyun
    Sung, Yon Mi
    Chung, Dong Hae
    Jeong, Sung Hwan
    Park, Jeong-Woong
    Lee, Sang Pyo
    KOREAN JOURNAL OF PARASITOLOGY, 2015, 53 (03): : 321 - 327
12345